Severe intrahepatic cholestasis in patients treated with recombinant interleukin-2 and lymphokine-activated killer cells. [electronic resource]
Producer: 19890620Description: 175-8 p. digitalISSN:- 0171-5216
- Adult
- Blood Transfusion, Autologous
- Cholestasis, Intrahepatic -- etiology
- Combined Modality Therapy
- Female
- Humans
- Hyperbilirubinemia -- etiology
- Immunization, Passive -- adverse effects
- Interleukin-2 -- adverse effects
- Killer Cells, Natural -- drug effects
- Leukapheresis
- Liver Diseases -- complications
- Liver Function Tests
- Lymphocyte Activation -- drug effects
- Melanoma -- secondary
- Middle Aged
- Recombinant Proteins -- adverse effects
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.